04Jun
Cannabis-Derived Ingredients in FDA-Regulated Products: More Questions than Answers at FDA’s May 2019 Public Hearing
As most folks with any interest in the burgeoning cannabidiol (CBD) industry likely know, on May 31, 2019, the Food and Drug Administration held a public hearing “to obtain scientific data and information about the safety, manufacturing, product...
By:
Mintz - Consumer Product Safety Viewpoints
Related
Governor Mike DeWine recently signed Senate Bill (S.B.) 57 into law, paving the way for the hemp ind...
Read More >
Employers in Ontario will likely welcome the decision in Katz et al. v. Clarke, 2019 ONSC 2188 (Divi...
Read More >
Trademark due diligence is the process of analyzing information concerning a company's trademark por...
Read More >
Driving safely is impossible if you’re impaired. It’s why driving while impaired by any legal or p...
Read More >
The viral outbreak that exploded out of central China suddenly has captured the rapt attention of Wa...
Read More >
In Saunders v. Florida Peninsula Insurance Co., a Florida appellate court recently determined whethe...
Read More >